From basic immuno-oncology research to innovative cancer immunotherapies

 

 

Choose one of the following research fields to find detailed scientific data and application protocols for your
 immuno-oncology research workflow:

Engineered T cells for research

Tumor infiltrating leukocytes

Monocytes and Mo-DCs

NK cells

Interested in our clinical applications? Choose one of the following research fields to discover application data and protocols for your translational immuno-oncology workflow:

GMP-engineered T cells

Regulatory T cells for immunotherapy

Dendritic cells for immunotherapy

T cell depletion in graft engineering

What’s the role of Miltenyi Biotec in immuno-oncology research?

Immuno-oncology research focuses on innovative approaches that exploit the immune system for cancer therapy by targeting cellular or molecular structures to prevent tumor immune evasion.

As an innovative biotechnology company, we at Miltenyi Biotec offer cutting-edge technologies and high-quality products to support your immuno-oncology research.

Whether you are interested in studying immune cells or cancer cells from the tumor microenvironment, or cellular models for the validation of novel immunotherapeutic agents – check out our application pages for the respective cell types (engineered T cells for research, monocytes and Mo-DCs, NK cells, tumor-infiltrating leukocytes (TILs)) to find relevant application data and protocols based on our immuno-oncology products. 

For example, download our scientific poster on the right, to learn about our automated TIL isolation and analysis workflow. 
 

Moreover, we offer clinical-scale immuno-oncology products for an easy transition of your research workflows into the clinic (engineered T cells, dendritic cells for immunotherapy, regulatory T cells for immunotherapy, T cell depletion in graft engineering). 

Do you, for example, know our T cell transduction process depicted in the figure below?

Workflow overview for the CAR T Cell Manufacturing Process on the CliniMACS Prodigy®

View details
Download PDF
Scientific poster
Workflow automation and parallelization improves the isolation and analysis of tumor-infiltrating immune cell subpopulations
Related PDFs:

Generation of functional CAR T cells from CD4+ and CD8+ T cells (Application note)

Generation of functional CAR T cells from pan T cells isolated by MACS® technology (Application note)

MACS® Technology facilitates mixed lymphocyte reaction (Application note)

Antigen-specific restimulation of CD8+ T cells by cross-presenting dendritic cells (Application note)

Allogenic T cell infusion alters iron regulatory gene expression (customer protocol)

Adoptive transfer of pan T cells separated with MACS® Technology (customer protocol)

Fast and efficient T cell isolation without density 
gradient centrifugation for CAR T cell engineering (Application note)

Get your CAR T cell research moving (brochure)

Flow cytometric assays with automated data acquisition and analysis for CAR T cell manufacturing and patient immunomonitoring (scientific poster)

So, what’s your immuno-oncology research story? 

Are you new to the immuno-oncology field or an experienced researcher, ready to tell your success story? Check out our immuno-oncology activities to find relevant webinars, talks, meetings, or the opportunity to win a travel award to selected meetings and the chance to share your research insights with the scientific community. 

Click on the link below to explore
immuno-oncology activities supported by Miltenyi Biotec

 

Seems like you are coming from USA!
Do you want to visit our website in your country?

Copyright © 2021 Miltenyi Biotec and/or its affiliates. All rights reserved.